HY-10015-10mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-100mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-25mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-5mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-50mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-100164-10mg
|
MedChemexpress LLC
|
SDZ-MKS 492 [CAS 114606-56-3]
|
|
COVID-19-immunoregulation
|
|
HY-100164-100mg
|
MedChemexpress LLC
|
SDZ-MKS 492 [CAS 114606-56-3]
|
|
COVID-19-immunoregulation
|
|
HY-100164-5mg
|
MedChemexpress LLC
|
SDZ-MKS 492 [CAS 114606-56-3]
|
|
COVID-19-immunoregulation
|
|
HY-100164-50mg
|
MedChemexpress LLC
|
SDZ-MKS 492 [CAS 114606-56-3]
|
|
COVID-19-immunoregulation
|
|
HY-100775-10mg
|
MedChemexpress LLC
|
Fezagepras (sodium) [CAS 1254472-97-3]
|
|
COVID-19-immunoregulation
|
|
HY-100775-100mg
|
MedChemexpress LLC
|
Fezagepras (sodium) [CAS 1254472-97-3]
|
|
COVID-19-immunoregulation
|
|
HY-100775-5mg
|
MedChemexpress LLC
|
Fezagepras (sodium) [CAS 1254472-97-3]
|
|
COVID-19-immunoregulation
|
|
HY-100775-50mg
|
MedChemexpress LLC
|
Fezagepras (sodium) [CAS 1254472-97-3]
|
|
COVID-19-immunoregulation
|
|
HY-101311-5mg
|
MedChemexpress LLC
|
UPF-523 [CAS 168560-79-0]
|
|
COVID-19-immunoregulation
|
|
HY-101559-50ug
|
MedChemexpress LLC
|
10-Nitrooleic acid [CAS 875685-46-4]
|
|
COVID-19-immunoregulation
|
|
HY-103637A-1mg
|
MedChemexpress LLC
|
Vimirogant (hydrochloride) [CAS 1802678-42-7]
|
|
COVID-19-immunoregulation
|
|
HY-103637A-10mg
|
MedChemexpress LLC
|
Vimirogant (hydrochloride) [CAS 1802678-42-7]
|
|
COVID-19-immunoregulation
|
|
HY-103637A-5mg
|
MedChemexpress LLC
|
Vimirogant (hydrochloride) [CAS 1802678-42-7]
|
|
COVID-19-immunoregulation
|
|
HY-104021-10mg
|
MedChemexpress LLC
|
GSK840 [CAS 2361146-30-5]
|
|
COVID-19-immunoregulation
|
|
HY-104021-100mg
|
MedChemexpress LLC
|
GSK840 [CAS 2361146-30-5]
|
|
COVID-19-immunoregulation
|
|
HY-104021-5mg
|
MedChemexpress LLC
|
GSK840 [CAS 2361146-30-5]
|
|
COVID-19-immunoregulation
|
|
HY-104021-50mg
|
MedChemexpress LLC
|
GSK840 [CAS 2361146-30-5]
|
|
COVID-19-immunoregulation
|
|
HY-10439-10mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|
HY-10439-100mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|
HY-10439-5mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|